Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Subject : brain neoplasms Subject : dacarbazine Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.

  • Authors : Xu P; The Fourth Department of Geronotology, Jinan Military General Hospital, Jinan, 250031, Shandong, China.; Zhang G

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2018 Oct; Vol. 106, pp. 1419-1427. Date of Electronic Publication: 2018 Jul 24.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Improved survival of Swedish glioblastoma patients treated according to Stupp.

  • Authors : Bruhn H; Section of Neurology, Department of Internal Medicine, County Hospital Ryhov, Jönköping, Sweden.; Strandéus M

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*mortality ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*therapy

  • Source: Acta neurologica Scandinavica [Acta Neurol Scand] 2018 Oct; Vol. 138 (4), pp. 332-337. Date of Electronic Publication: 2018 Jun 08.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway.

  • Authors : Zhang C; Department of Emergency, Zoucheng Affiliated Hospital of Jining Medical University, Zoucheng, 273500, PR China.; Yang X

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*pharmacology ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*therapy ; Dacarbazine/Dacarbazine/Dacarbazine/*analogs & derivatives

  • Source: Gene [Gene] 2018 Sep 25; Vol. 672, pp. 172-179. Date of Electronic Publication: 2018 Jun 12.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide.

  • Authors : Frontiñán-Rubio J; Department of Medical Sciences, Faculty of Medicine, University of Castilla-la Mancha, Ciudad Real, Spain; Oxidative Stress and Neurodegeneration Group, Regional Centre for Biomedical Research, Ciudad Real, Spain.

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*radiotherapy ; Dacarbazine/Dacarbazine/Dacarbazine/*analogs & derivatives ; Glioblastoma/Glioblastoma/Glioblastoma/*radiotherapy

  • Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2018 Aug; Vol. 128 (2), pp. 236-244. Date of Electronic Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.

  • Authors : Ramalho MJ; LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, R. Dr. Roberto Frias, 4200-465 Porto, Portugal.; Sevin E

Subjects: Drug Carriers* ; Nanoparticles*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*metabolism

  • Source: International journal of pharmaceutics [Int J Pharm] 2018 Jul 10; Vol. 545 (1-2), pp. 84-92. Date of Electronic Publication: 2018 Apr 30.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling.

  • Authors : Hanif F; Institute of Biomedical Sciences, Dow University of Health Sciences, Ojha Campus, SUPARCO Road, Karachi, Pakistan; Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan. Electronic address: .

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*pharmacology ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Dacarbazine/Dacarbazine/Dacarbazine/*analogs & derivatives

  • Source: Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2018 Oct; Vol. 52, pp. 306-313. Date of Electronic Publication: 2018 Jul 09.Publisher: Pergamon Press Country of Publication: England NLM ID: 8712158 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study].

  • Authors : Chaskis E; Hôpital Erasme, service de neurochirurgie, 808, route de Lennik, 1070 Bruxelles, Belgique.; Luce S

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*administration & dosage ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Dacarbazine/Dacarbazine/Dacarbazine/*analogs & derivatives

  • Source: Bulletin du cancer [Bull Cancer] 2018 Jul - Aug; Vol. 105 (7-8), pp. 664-670. Date of Electronic Publication: 2018 Jun 22.Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917

Record details

Read More Add to Saved list
×
Academic Journal

Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.

  • Authors : Kulason KO; Brain Tumor Center, Department of Neurosurgery, Lenox Hill Hospital, New York, NY, U.S.A.; Schneider JR

Subjects: Dose Fractionation, Radiation*; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*administration & dosage ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*administration & dosage

  • Source: Journal of experimental therapeutics & oncology [J Exp Ther Oncol] 2018 May; Vol. 12 (3), pp. 223-229.Publisher: Old City Publishing Country of Publication: United States NLM ID: 9604933 Publication Model: Print Cited Medium: Print ISSN: 1359-4117

Record details

Connect Read More Add to Saved list
×
Academic Journal

β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.

  • Authors : Wang N; Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China.; Zhang Q

Subjects: ATP Binding Cassette Transporter, Subfamily B/ATP Binding Cassette Transporter, Subfamily B/ATP Binding Cassette Transporter, Subfamily B/*metabolism ; ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism ; Anisoles/Anisoles/Anisoles/*pharmacology

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2017 Jun; Vol. 90, pp. 368-374. Date of Electronic Publication: 2017 Apr 02.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.

  • Authors : Banelli B; Laboratory of Tumor Epigenetics, IRCCS AOU San Martino-IST, Genova, Italy.; Department of Health Sciences, University of Genova, Genova, Italy.

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Dacarbazine/Dacarbazine/Dacarbazine/*analogs & derivatives ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*drug effects

  • Source: Oncotarget [Oncotarget] 2017 May 23; Vol. 8 (21), pp. 34896-34910.Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×